Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGIN

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Markets will remain closed on April 17, 2024 on account of Ram Navami.

GLOBAL LONGLIFE Share Price   (GLLE)



Here is the latest stock price and chart of GLOBAL LONGLIFE. For more details, see the GLOBAL LONGLIFE company fact sheet and quarterly results.

For You: Midcap Stocks Research at Less than Its Launch Price

REFRESH
Live BSE Quotes Apr 16, 2024 (Close)
Price (Rs)43.29 Open (Rs) 43.29 High (Rs) 43.29 Low (Rs) 43.29
% Change4.31 Volume 1,000 Value (Rs) 43,290 52-Week H/L 61.70 / 36.25
Live NSE Quotes
Not listed
Change
1 Day
4.31%		1 Month
-1.34%		3 Months
-21.29%		1 Year
-4.86%
Valuation
EPS (Rs)* - P/E Ratio (x) - Market Cap (Rs m) 454.55 P/BV (x) 0.70 Dividend Yield (%) 0.00
  *Trailing 12 months earnings, excluding extraordinary / exceptional items. BSE Sensex | CNX Nifty

Charts
Loading...
  
Peer Group:
Quote & Graph
     
 S&P BSE SENSEX 
PERIOD
Advanced Charts new
Charts by TradingView

GLOBAL LONGLIFE Share Price Today:

GLOBAL LONGLIFE last traded price was up 4.3% to Rs 43.3 on the BSE. The total volume of shares traded was 0.0 m.

Overall, the benchmark S&P BSE SENSEX was at 72,943.7 (down 0.6%).

Over the last 30 days, the GLOBAL LONGLIFE share price is up 0.7%. And over the last one year, GLOBAL LONGLIFE share price is down 7.8%.

The current market capitalisation of GLOBAL LONGLIFE stands at Rs 454.55 m. For more information, check out the list of top 100 companies in India in terms of market cap.

As of December 2023, company promoters held 54.29% stake in GLOBAL LONGLIFE, with no shares having been pledged. To know more, check out the latest shareholding pattern of GLOBAL LONGLIFE.



FAQs on GLOBAL LONGLIFE

What is the GLOBAL LONGLIFE share price today?

The last traded price of GLOBAL LONGLIFE was Rs 43.3 on the BSE, up 4.3% over the previous close.

What is the market cap of GLOBAL LONGLIFE?

The current market capitalisation of GLOBAL LONGLIFE stands at Rs 455 m.

Which are the top diagnostics companies in India by marketcap?

Based on marketcap, these are the top diagnostics companies in India:

You can see the full list of diagnostics stocks ranked by marketcap here.

Also, here's one of our more popular screens related to marketcap: India's Biggest Companies by Marketcap.

Which are the biggest diagnostics companies in India by sales?

Based on sales, these are the top diagnostics companies in India:

You can see the full list of diagnostics stocks.

Curious to know which Indian companies are growing their sales at a faster rate than their peers? Check out India's Fastest Growing Companies by Sales.

Which are the biggest diagnostics companies in India by net profit?

Based on net profit, these are the top diagnostics companies in India:

You can see the full list of diagnostics stocks.

In case you are wondering which company logs in the biggest net profit margin in India, check this out: High Profit Margin Companies in India.


Today's Market

Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling Sensex Today Ends 456 Points Lower | IT Stocks Drag | 5 Reasons Why Indian Share Market is Falling(Closing)

After opening the negative note, Indian share markets Slipped further as the session progressed and ended the day weak.

ABOUT EQUITYMASTER

Since 1996, Equitymaster has been the source for honest and credible opinions on investing in India. With solid research and in-depth analysis Equitymaster is dedicated towards making its readers- smarter, more confident and richer every day. Here's why hundreds of thousands of readers spread across more than 70 countries Trust Equitymaster.

PREMIUM PRODUCTS
QUICK LINKS
POPULAR TOPICS
TRENDING TOPICS
FREE NEWSLETTERS
EQUITYMASTER SUPPORTS
  • HelpYourNGO
  • You Tube
  • Linkedin
  • Twitter
  • Telegram
  • Google Play

Copyright © Equitymaster Agora Research Private Limited.

Whitelist | Refer | Terms | Privacy | Contact | About | Sitemap

Phone +91-9136015013

Equitymaster Agora Research Private Limited (Research Analyst)
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
Telephone: +91-22-61434055. Email: info@equitymaster.com. Website: www.equitymaster.com.
CIN:U74999MH2007PTC175407

Name of the Compliance & Grievance Officer: Ms Sonal Ramachandran
Telephone: +91-22-61434003 | Email: compliance@equitymaster.com

LEGAL DISCLAIMER:
Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Registration granted by SEBI and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

All rights reserved. Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

Equitymaster Agora Research Private Limited (Research Analyst) bearing Registration No. INH000000537 (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA, Canada or the European Union countries, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.